7 Day Study of Mast Cell Inhibitor, R926112, in Patients With Symptomatic Seasonal Allergic Rhinitis
Completed
Rigel Pharmaceuticals
Phase 2
2005-07-01
This is a study of the effectiveness and safety of a new nasal spray for the relief of the
symptoms of seasonal allergies. The agents being compared are: R926112 (a novel anti-allergy
medicine), Beconase (beclomethasone dipropionate, an established FDA approved steroid
treatment), and an inactive placebo. The study hypothesis is that R926112 will be superior to
placebo at the end of a week of testing and evaluation. The study does not have the power to
determine how R926112 compares to Beconase.
Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
Completed
Fred Hutchinson Cancer Research Center
Phase 2
2007-04-01
RATIONALE: Beclomethasone dipropionate may be effective in preventing acute graft-versus-host
disease in patients undergoing a stem cell transplant for hematologic cancer.
PURPOSE: This randomized phase II trial is studying how well beclomethasone dipropionate
works in preventing acute graft-versus-host disease in patients undergoing a donor stem cell
transplant for hematologic cancer.
Patients that have consented to participate in the study will be randomly assigned to one of
two groups: control group or nasal steroid group. Patients in the control group will receive
normal saline inhaler. Patients in the study group will receive steroid inhaler Follow-up
visits are: baseline and weeks 2, 4, 6 after starting the spray. Intraocular pressure will be
recorded on all visits.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.